SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Covetrus, Inc. (CVET) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 28/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CVET
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.63
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.63
Book Value / Share$0.00
Revenue / Share$33.39
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.54 |
$2.98B |
$60.32M |
2% |
| 2016 |
$0.63 |
$3.35B |
$70.3M |
2.1% |
| 2017 |
$0.58 |
$3.58B |
$64.35M |
1.8% |
| 2018 |
$0.91 |
$3.78B |
$100.86M |
2.7% |
| 2019 |
$-9.52 |
$3.98B |
$-1.02B |
-25.6% |
| 2020 |
$-0.16 |
$4.34B |
$-19M |
-0.4% |
| 2021 |
$-0.63 |
$4.58B |
$-86M |
-1.9% |
